BAK1 and cancer: At the same time, the low-glucose tumor microenvironment prevents the activation of Bcl-2-associated X protein (BAX) and Bcl-2 homologous antagonist/killer (BAK) proteins (present on the surface of mitochondria) in cancer cells, thus inhibiting mitochondrial disruption and apoptosis [35].